Kotani N, Asano M, Iwakura Y, Takasaki S
Division of Biochemistry, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Biochem J. 2001 Aug 1;357(Pt 3):827-34. doi: 10.1042/0264-6021:3570827.
To understand the contribution of beta 1,4-galactosyltransferase (beta 4Gal-T)-1 to galactosylation in vivo, N-glycans of hepatic membrane glycoproteins and plasma glycoproteins from beta 4Gal-T1 wild-type (beta 4Gal-T1(+/+)) and beta 4Gal-T1 knockout mice were compared. Unexpectedly, glycoproteins from the knockout mice were found to express considerable amounts of sialylated, galactosylated N-glycans. A striking contrast was that galactose residues were largely beta 1,4-linked to GlcNAc residues in the beta 4Gal-T1(+/+) mouse glycans but beta 1,3-linked in the knockout mouse glycans, thus resulting in the shift of the backbone structure from type 2 chain (Gal beta 1-->4GlcNAc) to type 1 chain (Gal beta 1-->3GlcNAc). Detailed analysis of plasma glycoproteins revealed that the expression of sialyl linkage in N-glycans was shifted from the Sia alpha 2-->6Gal to the Sia alpha 2-->3Gal, and oversialylated type 1 chains were, remarkably, found in the knockout mouse glycans. Thus beta 4Gal-T1 deficiency was primarily compensated for by beta1,3-galactosyltransferases, which resulted in different sialyl linkages being formed on the outer chains and altered backbone structures, depending on the acceptor specificities of sialyltransferases. These results suggest that beta 4Gal-T1 in mouse liver plays a central role in the synthesis of type 2 chain and is also involved in the regulation of sialylation of N-glycans. The knockout mice may prove useful in investigation of the mechanism which regulates the tissue-dependent terminal glycosylation.
为了解β1,4-半乳糖基转移酶(β4Gal-T)-1在体内半乳糖基化过程中的作用,对β4Gal-T1野生型(β4Gal-T1(+/+))和β4Gal-T1基因敲除小鼠肝脏膜糖蛋白及血浆糖蛋白的N-聚糖进行了比较。出乎意料的是,发现基因敲除小鼠的糖蛋白表达了相当数量的唾液酸化、半乳糖基化N-聚糖。一个显著的对比是,在β4Gal-T1(+/+)小鼠聚糖中,半乳糖残基主要以β1,4-连接到GlcNAc残基上,而在基因敲除小鼠聚糖中则是β1,3-连接,从而导致主链结构从2型链(Galβ1→4GlcNAc)转变为1型链(Galβ1→3GlcNAc)。对血浆糖蛋白的详细分析表明,N-聚糖中唾液酸连接的表达从Siaα2→6Gal转变为Siaα2→3Gal,并且在基因敲除小鼠聚糖中显著发现了过度唾液酸化的1型链。因此,β4Gal-T1缺陷主要由β1,3-半乳糖基转移酶代偿,这导致根据唾液酸转移酶的受体特异性,在外链上形成不同的唾液酸连接并改变主链结构。这些结果表明,小鼠肝脏中的β4Gal-T1在2型链的合成中起核心作用,并且还参与N-聚糖唾液酸化的调节。基因敲除小鼠可能有助于研究调节组织依赖性末端糖基化的机制。